Flyte Aviation Inc. (VJET)
VJET trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1716621/000143774926010549/0001437749-26-010549-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | VJET on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001716621 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $819K |
| Net income | -$17.2M |
| Operating income | -$21.1M |
| Net margin | -2098.0% |
| Operating margin | -2581.6% |
| Revenue growth | +95.0% |
| Cash | $88K |
| Total assets | $15.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of the unaudited condensed consolidated financial statements." | 10-Q 2026-08-14 |
| Cash and burn | $643K cash; operating cash flow -$2.3M a quarter. | Report 2026-06-30 |
| Shares outstanding | 1,439,194 (2026-08-10); 23,327,516 a year earlier; 5,367,674 three years earlier. 1y figure adjusted for splits (1-for-19 overall); 3y figure adjusted for splits (1-for-190 overall). | Cover page 2026-08-10 |
| Reverse splits, 3 years | 3; latest 1-for-10 on 2026-10-05 | Source 2026-10-05 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | WithumSmith+Brown, PC, East Brunswick, New Jersey, United States | PCAOB Form AP 2026-04-02 |
| Late filings, 12 months | 1 NT notice | NT 10-Q 2026-05-18 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $1.0M | -$3.3M | -$2.9M | $643K | $0 | $1.9M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $432K | -$1.7M | -$2.8M | $441K | $6.8M | $1.1M | 10-Q 2026-05-18 |
| Q4 2025 2025-12-31 | $238K | -$5.8M | -$1.5M | $88K | $3.1M | $819K | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $226K | -$2.3M | -$2.2M | $1.1M | $1.5M | $730K | 10-Q 2025-11-13 |
| Q2 2025 2025-06-30 | $212K | -$5.1M | -$2.3M | $838K | $1.5M | $600K | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $143K | -$4.0M | -$2.3M | $450K | No debt tags | $481K | 10-Q 2026-05-18 |
| Q4 2024 2024-12-31 | $149K | -$5.6M | -$2.9M | $2.9M | $177K | $420K | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $96K | -$4.1M | -$2.8M | $1.3M | $249K | $399K | 10-Q 2024-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2026-08-21 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-30 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-16 |
| Latest current report FORM 8-K | 8-K | 2026-11-16 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-08-31 |
Source: SEC EDGAR submissions feed, 605 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.8% |
| 1 month | -53.8% |
| 3 months | -83.1% |
| Year to date | -97.3% |
| 1 year | -97.6% |
| From 52-week high | -98.4% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NXGL | NexGel Inc | $3.93 | +2.08% | $1.9M |
| AMIX | Autonomix Medical Inc. | $1.10 | -19.71% | $2.2M |
| CODX | Co-Diagnostics Inc. | $0.2249 | -13.03% | $2.4M |
| BJDX | Bluejay Diagnostics Inc. | $2.29 | -12.26% | $2.6M |
| ICCM | IceCure Medical Ltd. | $0.7601 | +4.12% | $2.6M |
| IVF | INVO Fertility Inc. | $2.40 | -7.69% | $2.8M |
| VVOS | Vivos Therapeutics Inc. | $0.0822 | -16.12% | $2.8M |
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier